Cargando…
Frequency of anticancer drug use at the end of life: a scoping review
PURPOSE: Anticancer drug use at the end of life places potential extra burdens on patients and the healthcare system. Previous articles show variability in methods and outcomes; thus, their results are not directly comparable. This scoping review describes the methods and extent of anticancer drug u...
Autores principales: | Szigethy, Endre, Dorantes, Rosario, Sugrañes, Miguel, Madera, Meisser, Sola, Ivan, Urrútia, Gerard, Bonfill, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247343/ https://www.ncbi.nlm.nih.gov/pubmed/37286888 http://dx.doi.org/10.1007/s12094-023-03234-1 |
Ejemplares similares
-
Evidence mapping and quality assessment of systematic reviews on therapeutic interventions for oral cancer
por: Madera Anaya, Meisser, et al.
Publicado: (2018) -
Anticancer Drugs Compared to No Anticancer Drugs in Patients with Advanced Hepatobiliary Cancer: A Mapping Review and Evidence Gap Map
por: Requeijo, Carolina, et al.
Publicado: (2023) -
Evidence mapping based on systematic reviews of therapeutic interventions for gastrointestinal stromal tumors (GIST)
por: Ballesteros, Mónica, et al.
Publicado: (2017) -
Therapeutic Options in Unresectable Oral Squamous Cell Carcinoma: A Systematic Review
por: Madera, Meisser, et al.
Publicado: (2021) -
Description of the Protocols for Randomized Controlled Trials on Cancer Drugs Conducted in Spain (1999–2003)
por: Bonfill, Xavier, et al.
Publicado: (2013)